Cell Priming, Receptor Cross-talk and Acute Lung Injury
Cell Priming, Receptor Cross-talk and Acute Lung Injury
批准号:
8602849
负责人:
Jie Fan
金额:
$30.82万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-29 至 2016-01-31
关键词:
Acute Lung InjuryAftercareAlveolar MacrophagesCause of DeathCellsCessation of lifeDevelopmentEndothelial CellsFeedbackGrantHemorrhagic ShockInfectionInflammationInflammation MediatorsInflammatoryInterleukin-1Interleukin-12LigandsLungLung InflammationMediatingMediator of activation proteinMorbidity - disease rateOrganPathogenesisPatientsPattern recognition receptorPlayProcessProductionReceptor Cross-TalkRoleSepsis SyndromeSignal TransductionSourceStimulusTLR2 geneTLR4 geneTestingTherapeutic InterventionTraumaUp-RegulationVascular Endotheliumbaseburden of illnesschemokine receptorcytokinehuman diseaseinsightmigrationmortalityneutrophilnovelnovel strategiespublic health relevancereceptorreceptor expressionresponsetoll-like receptor 4
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hemorrhagic shock (HS) resulting from severe trauma promotes the development of systemic inflammatory response syndrome (SIRS) by activating and priming the inflammatory process through as of yet unclear mechanisms. Acute lung injury (ALI) is a major component of SIRS and often serves as a direct cause of death to patients. The lung vascular endothelium is an active organ and plays a central role in the development of ALI through synthesis and release of a number of inflammatory mediators. IL-12 is a key cytokine with multiple effects on lung inflammatory processes. Lung endothelial cells (EC) are one important source of IL-12 in response to HS insult. Conversely, lung EC is targets of IL-12, causing the production of a range of inflammatory molecules, including IL-12 itself, in response to IL-12 stimulation. Thus, lung EC through interacting with IL-12 forms a feedback mechanism to amplify lung inflammation in HS. The production of active IL-12 is tightly controlled by Inflammasome. Despite the central role of IL-12 in the development of SIRS, anti-IL-12 therapy aimed at blocking IL-1 receptor has not been successful. Targeting at inflammasome, however, may present a novel anti-IL-12 strategy for post-trauma SIRS. However, the mechanism underlying HS initiation of inflammasome in the lung and EC is unclear. We have observed two receptor cross-talk mechanisms that might mediate HS activation and priming of inflammasome. We found that TLR4 signaling upregulates type I IL-1 receptor (IL-1RI), and thereby sensitizing the cells to IL-12 stimulation; and HS enhances Toll-like receptor (TLR)4 signaling upregulation of TLR2 in lung EC, which in turn augments IL-12 release in response to TLR2 ligands. In the proposed study we will test the hypotheses that: 1) HS through targeting lung EC inflammasome promotes the development of ALI; 2) cross-talk of TLR4- IL-1RI is a novel feedback mechanism amplifying lung inflammation in HS; and 3) cross-talk of TLR4-TLR2 serves as an important mechanism mediating HS-primed inflammasome activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLRD Research Career Scientist Award Application
-
批准号:10696603
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:Jie Fan
-
依托单位:
Regulatory Role of ILC2 in Acute Lung Injury in Sepsis
-
批准号:10618774
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Jie Fan
-
依托单位:
Regulatory Role of ILC2 in Acute Lung Injury in Sepsis
-
批准号:9885001
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Jie Fan
-
依托单位:
Regulatory Role of ILC2 in Acute Lung Injury in Sepsis
-
批准号:10293529
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Jie Fan
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:9899091
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Jie Fan
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:10265421
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Jie Fan
-
依托单位:
Macrophage Pyroptosis Mechanism of Post-Trauma Acute Lung Injury
-
批准号:10260392
-
项目类别:
-
资助金额:$39.13万
-
财政年份:2018
-
负责人:Jie Fan
-
依托单位:
Macrophage Pyroptosis Mechanism of Post-Trauma Acute Lung Injury
-
批准号:9593050
-
项目类别:
-
资助金额:$39.13万
-
财政年份:2018
-
负责人:Jie Fan
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:10454216
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Jie Fan
-
依托单位:
Aging-Related Mechanism of Post-Hemorrhagic Shock Acute Lung Injury
-
批准号:9130376
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2015
-
负责人:Jie Fan
-
依托单位:
Cell Death Mechanism of Acute Lung Injury in Sepsis
-
批准号:9275434
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Jie Fan
-
依托单位:
Cell Death Mechanism of Acute Lung Injury in Sepsis
-
批准号:8816408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Jie Fan
-
依托单位:
Cell Death Mechanism of Acute Lung Injury in Sepsis
-
批准号:9794744
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Jie Fan
-
依托单位:
Cell Death Mechanism of Acute Lung Injury in Sepsis
-
批准号:10002181
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Jie Fan
-
依托单位:
Project 4: Hemorrhagic Shock Regulation of Inflammasome
-
批准号:7751469
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2009
-
负责人:Jie Fan
-
依托单位:
Cell Priming, Receptor Cross-Talk, and Acute Lung Injury
-
批准号:7236137
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2005
-
负责人:Jie Fan
-
依托单位:
Cell Priming, Receptor Cross-Talk, and Acute Lung Injury
-
批准号:9233176
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2005
-
负责人:Jie Fan
-
依托单位:
Cell Priming, Receptor Cross-Talk, and Acute Lung Injury
-
批准号:7637436
-
项目类别:
-
资助金额:$23.52万
-
财政年份:2005
-
负责人:Jie Fan
-
依托单位:
Cell Priming, Receptor Cross-Talk, and Acute Lung Injury
-
批准号:6966057
-
项目类别:
-
资助金额:$29.21万
-
财政年份:2005
-
负责人:Jie Fan
-
依托单位:
Cell Priming, Receptor Cross-Talk, and Acute Lung Injury
-
批准号:7439150
-
项目类别:
-
资助金额:$23.53万
-
财政年份:2005
-
负责人:Jie Fan
-
依托单位:
海外基金